(INDIANAPOLIS) - An Indianapolis-based drug maker is experiencing success in a downturn economy.
Eli Lilly reports gains in revenue and net income during its fiscal second quarter.
The fifth-largest biotech company in the US says it earned $1.15 billion, a 21%climb from the net income reported in the same period in 2008.
Have a question or comment about a news story? Send it to firstname.lastname@example.org